SOLID BIOSCIENCES INC.
Profile
Company Names
SOLID BIOSCIENCES INC.
Addresses
500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA 02129
141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE, MA 02139
141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE, MA 02139
Phone Numbers
617-337-4680
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$109,177,031.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-12-02
$9,200,000.00
$9,200,000.00
$0.00
Equity
2
2020-10-22
$39,999,996.00
$39,999,996.00
$0.00
Equity
1
2019-07-30
$59,977,035.00
$59,977,035.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MATTHEW
ARNOLD
DIRECTOR
MARTIN
FREED
DIRECTOR
ADAM
KOPPEL
DIRECTOR
SUKUMAR
NAGENDRAN
DIRECTOR
RAJEEV
SHAH
DIRECTOR
CIVITAS THERAPEUTICS, INC.
| KALA PHARMACEUTICALS, INC.
| RA PHARMACEUTICALS, INC.
| SATSUMA PHARMACEUTICALS, INC.
| EIDOS THERAPEUTICS, INC.
| BLACK DIAMOND THERAPEUTICS, INC.
| RA CAPITAL HEALTHCARE FUND LP
| RA CAPITAL HEALTHCARE INTERNATIONAL FUND LTD
| SOLID BIOSCIENCES INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND, L.P.
| RA CAPITAL NEXUS FUND, L.P.
| CELONA, INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND III, L.P.
| RA CAPITAL NEXUS FUND III, L.P.
| ABCURO, INC.
| RA CAPITAL PLANETARY HEALTH FUND, L.P.
| RA CAPITAL PLANETARY HEALTH INTERNATIONAL FUND, L.P.
IAN
SMITH
DIRECTOR
CARGURUS LLC
| CROSSHAIR EXPLORATION + MINING CORP
| YELLOWHEAD MINING INC.
| MAX RESOURCE CORP.
| FUNKY EYES INTERNATIONAL, INC.
| XAPO HOLDINGS LTD
| CATHEDRAL LAKE II, LTD.
| CATHEDRAL LAKE III, LTD.
| CATHEDRAL LAKE CLO 2013, LTD.
| FOODTRUCKR, LLC
| AURORA INNOVATION, INC.
| CARGURUS, INC.
| VIACYTE INC.
| SANATANA RESOURCES INC
| SOLID BIOSCIENCES INC.
| AURORA INNOVATION, INC.
| ODYSSEY THERAPEUTICS, INC.
| RIVUS PHARMACEUTICALS, INC.
ADAM
STONE
DIRECTOR
ANDREY
ZARUR
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2022-12-02
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-10-22
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-07-30

